Finance

Lists
Q1 2027 earnings • released • EPS beat +64.70% • Revenue beat +0.52%
See results
ANGO:NASDAQ
AngioDynamics, Inc.
$11.39
-1.13%
(-0.13) 1D
Oct 12, 2:07:30 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANGO...
Open
$11.42
High
$11.70
Low
$11.30
Mkt. cap
480.68M
Avg. vol.
682.01K
Volume
479.38K
52-wk high
$16.29
52-wk low
$9.39
EPS
-$0.88
Beta
0.30
Shares outstanding
42.05M
No. of employees
632
Open
$11.42
High
$11.70
Low
$11.30
Mkt. cap
480.68M
Avg. vol.
682.01K
Volume
479.38K
52-wk high
$16.29
52-wk low
$9.39
EPS
-$0.88
Beta
0.30
Shares outstanding
42.05M
No. of employees
632
News stories
From web sources and news partners
About AngioDynamics, Inc.
CEOJames Clemmer
Employees632
FoundedFeb 9, 1988
Headquarters-
SectorMedical device
Websiteangiodynamics.com
Analyst ratings
Based on 3 analysts giving stock ratings to ANGO in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ANGO in the last 3 months.
Highest
Current $11.39
$24.00 (+110.71%)
Average
$21.00 (+84.37%)
Lowest
$19.00 (+66.81%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Young CFA
Canaccord Genuity
Buy
Reiterated
$20.00
+75.6%
10/09/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$19.00
+66.8%
07/16/2026
Frank Takkinen
Lake Street
Buy
Maintained
$24.00
+110.7%
07/14/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Initiated
$16.00
+40.5%
04/06/2026
Last report
Oct 8, 2026
Fiscal period
Q1 2027
-$0.04 / -$0.11
+64.70%beat
Revenue / Est. (USD)
80.92M / 80.50M
+0.52%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Nov 2025
Feb 2026
May 2026
Aug 2026
Revenue
79.43M
78.42M
86.61M
80.92M
Cost of goods sold
34.65M
36.94M
39.83M
34.08M
Cost of revenue
34.65M
36.94M
39.83M
33.28M
Research and development expenses
7.63M
6.93M
8.03M
7.98M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37.00M
38.31M
41.53M
42.61M
Operating expense
47.27M
47.91M
52.42M
53.16M
Total operating expenses
81.92M
84.85M
92.26M
87.24M
Operating income
-2.49M
-6.43M
-5.65M
-5.52M
Other non operating income
-128.00K
4.97M
-735.00K
94.00K
EBT including unusual items
-6.36M
-8.07M
-11.04M
-7.30M
EBT excluding unusual items
-2.72M
-1.55M
-6.49M
-6.32M
Income tax expense
-5.00K
12.00K
370.00K
-199.00K
Effective tax rate
0.08%
-0.15%
-3.35%
2.73%
Other operating expenses
-
-
138.00K
-
Net income
-6.35M
-8.08M
-11.40M
-7.10M
Net profit margin
-7.99%
-10.31%
-13.17%
-8.77%
Earnings per share
-
0.02
-0.07
-0.04
Interest and investment income
-
12.00K
1.00K
-
Interest expense
-102.00K
-100.00K
-106.00K
-88.00K
Net interest expenses
-102.00K
-88.00K
-105.00K
-88.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
3.26M
-838.00K
-353.00K
-23.00K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps